previous compound ID: 552 next compound
InChIKey: FBOZXECLQNJBKD-ZDUSSCGKSA-N
SMILES: CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Liao" "SD Macknight" "E Matthes" "DY Thomas" "R Robert" "GW Carlile" "B Kus" "D Rotin" "JW Hanrahan" "J Goepp"

chemical graph of compound 552





CID is 126941
synonyms found at PubChem are:
methotrexate, 59-05-2, Rheumatrex, Abitrexate, Amethopterin, Trexall, Mexate, Metatrexan, Hdmtx, Methylaminopterinum, Antifolan, Ledertrexate, Methylaminopterin, Methotrexatum, Methotrexat, Metotrexato, MTX, 4-Amino-10-methylfolic acid, L-Amethopterin, (S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid, Folex, N-Bismethylpteroylglutamic acid, Amethopterine, Methoxtrexate, Maxtrex, Rasuvo, A-Methopterin, Mexate-Aq, A-Methpterin, Emtexate, Amethopterin L-, Folex-Pfs, Methotrexat-Ebewe, Methotrexate, L-, Methotrexate Lpf, Metotressato [DCIT], Folex Pfs, Methotextrate, METHOTREXATE SODIUM, 133073-73-1, NSC 740, NSC-740, CL-14377, NCI-C04671, UNII-YL5FZ2Y5U1, [3H]methotrexate, Methotrexatum [INN-Latin], Metotrexato [INN-Spanish], (+)-4-Amino-10-methylfolic acid, [3H]-methotrexate, EMT 25,299, CCRIS 1109, 4-Aminomethylpteroylglutamic acid, HSDB 3123, TCMDC-125858, Abitrexate (Methotrexate), EINECS 200-413-8, R 9985, YL5FZ2Y5U1, CHEMBL34259, (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid, AI3-25299, NSC740, X 133, 4-Amino-N(sup 10)-methylpteroylglutamic acid, CHEBI:44185, L-(+)-N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid, (2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid, N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-(+)-glutamic acid, Antifolan hydrate, MTX hydrate, Kyselina 4-amino-N(sup 10)-methylpteroylglutamova [Czech], NCGC00025060-04, C20H22N8O5, CL 14377, 4-amino-N(10)-methylpteroylglutamic acid, DSSTox_CID_822, Mexate-Aq Preserved, N-(p-(((2,4-Diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid, N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamicacid, DSSTox_RID_75810, Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova [Czech], DSSTox_GSID_20822, Methylaminopterin hydrate, Fauldexato, Medsatrexate, Methoblastin, Metotressato, Brimexate, Emthexat, Emthexate, Lantarel, Lumexon, Metrotex, Novatrex, Otrexup, Tremetex, Trexeron, Trixilem, Metex, Texate, MLS001401431, Methotrexate Preservative Free, MFCD00150847, (4-(((2,4-diaminopteridin-6-yl)methyl)(methyl)amino)benzoyl)-L-glutamic acid, Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-, N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid, SMR000112001, 4-Amino-10-methylfolic acid hydrate, SR-01000075682, SMR000449324, METHOTREXATE SODIUM PRESERVATIVE FREE, Arbitrexate, FBOZXECLQNJBKD-UHFFFAOYSA-N, Methotrate, Metolate, Xatmep, Intradose-MTX, 1dhi, 1dhj, 2drc, 4ocx, (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid, N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid, N-{4-[[(2,4-diaminopteridin-6-yl)methyl](methyl)amino]benzoyl}-L-glutamic acid, CAS-59-05-2, Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova, (2S)-2-[(4-([(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO)PHENYL)FORMAMIDO]PENTANEDIOIC ACID, MPI-2505, Prestwick_322, Methotrexate [USAN:INN:BAN:JAN], Otrexup (TN), Xatmep (TN), folic acid antagonist, An-PDN, L-METHOTREXATE, Methotrexate 100mg, Methylaminopterin; MTX, DL-Amethopterin hydrate, Intrathecal methotrexate, Methotrexate [USAN:USP:INN:BAN:JAN], Spectrum_001836, Tocris-1230, 4kn0, WR-19039, METHYLAMINOPTERINE, N-(4-{[(2,4-Diaminopteridin-1-Ium-6-Yl)methyl](Methyl)amino}benzoyl)-L-Glutamic Acid, Prestwick0_000135, Prestwick1_000135, Prestwick2_000135, Spectrum2_001077, Spectrum3_000497, Spectrum4_000616, Spectrum5_000958, Methotrexate - Abitrexate, D07ALU, D0D3DU, D0SV8E, L(+)-Amethopterin hydrate, NCIMech_000767, SCHEMBL3711, BIDD:PXR0175, L-(+)-AMETHOPTERIN, Lopac0_000020, KBioGR_001172, KBioSS_002341, KSC269O8T, Kyselina 4-amino-N(sup 10)-methylpteroylglutamova, MLS000049968, MLS002154208, DivK1c_000114, SPBio_001094, SPBio_002149, AC1L2R79, cid_126941, cid_165528, GTPL4674, GTPL4815, DTXSID4020822, SCHEMBL12421860, BDBM18050, BDBM66082, CTK1G9789, HMS500F16, KBio1_000114, KBio2_002338, KBio2_004906, KBio2_007474, KBio3_001493, Methotrexate (JP17/USP/INN), AOB5585, FBOZXECLQNJBKD-ZDUSSCGKSA-N, g301, MolPort-003-665-521, NINDS_000114, Bio1_000486, Bio1_000975, Bio1_001464, HMS1568K12, HMS2095K12, HMS2233O18, HMS3260C21, HMS3712K12, ACT03341, APC-2002, BCP13701, KS-00000L8X, MPI-5004, ZINC1529323, Tox21_110944, Tox21_300269, Tox21_500020, ANW-72813, CCG-35800, LS-249, s1210, 15475-56-6 (hydrochloride salt), AKOS016340329, Tox21_110944_1, 7413-34-5 (di-hydrochloride salt), AB02593, ACN-050905, CL14377, CS-1732, DB00563, KS-5093, LP00020, MCULE-6523054194, RTR-020497, IDI1_000114, SMP2_000020, (methyl)amino)benzamido)pentanedioic acid, NCGC00025060-01, NCGC00025060-02, NCGC00025060-03, NCGC00025060-05, NCGC00025060-06, NCGC00025060-07, NCGC00025060-08, NCGC00025060-09, NCGC00025060-10, NCGC00025060-11, NCGC00025060-12, NCGC00025060-13, NCGC00025060-15, NCGC00025060-16, NCGC00254216-01, NCGC00260705-01, AJ-26587, BC202627, BR-77824, HY-14519, SC-19293, 4-Amino-N10-methylpteroyl-L-glutamic acid, EU-0100020, FT-0082628, FT-0601523, Methotrexate 1.0 mg/ml in Dimethyl Sulfoxide, 1771-EP0930075A1, 1771-EP2269989A1, 1771-EP2269994A1, 1771-EP2270001A1, 1771-EP2270008A1, 1771-EP2270018A1, 1771-EP2270505A1, 1771-EP2272825A2, 1771-EP2272827A1, 1771-EP2272832A1, 1771-EP2275413A1, 1771-EP2275420A1, 1771-EP2277565A2, 1771-EP2277566A2, 1771-EP2277567A1, 1771-EP2277568A2, 1771-EP2277569A2, 1771-EP2277570A2, 1771-EP2277865A1, 1771-EP2277876A1, 1771-EP2280012A2, 1771-EP2281563A1, 1771-EP2281815A1, 1771-EP2287156A1, 1771-EP2289892A1, 1771-EP2289894A2, 1771-EP2292233A2, 1771-EP2292280A1, 1771-EP2292595A1, 1771-EP2292614A1, 1771-EP2292615A1, 1771-EP2292617A1, 1771-EP2295055A2, 1771-EP2295416A2, 1771-EP2295426A1, 1771-EP2295427A1, 1771-EP2298743A1, 1771-EP2298748A2, 1771-EP2298764A1, 1771-EP2298765A1, 1771-EP2298768A1, 1771-EP2298772A1, 1771-EP2298778A1, 1771-EP2298780A1, 1771-EP2301928A1, 1771-EP2301933A1, 1771-EP2305243A1, 1771-EP2305640A2, 1771-EP2305642A2, 1771-EP2305660A1, 1771-EP2305668A1, 1771-EP2305671A1, 1771-EP2305679A1, 1771-EP2305689A1, 1771-EP2308833A2, 1771-EP2308839A1, 1771-EP2308855A1, 1771-EP2308861A1, 1771-EP2311453A1, 1771-EP2311807A1, 1771-EP2311808A1, 1771-EP2311825A1, 1771-EP2311827A1, 1771-EP2311829A1, 1771-EP2311840A1, 1771-EP2311842A2, 1771-EP2311850A1, 1771-EP2314590A1, 1771-EP2316459A1, 1771-EP2316832A1, 1771-EP2316833A1, 1771-EP2316834A1, 1771-EP2371811A2, 1771-EP2374454A1, 5947-EP0930075A1, 5947-EP2269994A1, 5947-EP2289892A1, 73M731, A-2190, C01937, D00142, J10045, DL-4-Amino-N10-methylpteroylglutamic acid hydrate, SR-01000597411, W-60383, (S)-2-(4-(((2,4-diaminopteridin-6-yl)methyl), I06-2098, Q-201366, SR-01000075682-1, SR-01000075682-2, SR-01000075682-6, SR-01000597411-1, W-105347, 2,2'-(9,10-anthracenediylidene)-bis-propanedinitrile, BRD-K59456551-001-09-3, BRD-K59456551-001-11-9, I14-18123, WLN: T66 BN DN GN JNJ CZ EZ H1N1&R DVMYVQ2VQ, Z1541638527, UNII-99ITO15X8S component FBOZXECLQNJBKD-ZDUSSCGKSA-N, Methotrexate, European Pharmacopoeia (EP) Reference Standard, Methotrexate, United States Pharmacopeia (USP) Reference Standard, Glutamic acid,4-diamino-6-pteridinyl)methyl] methylamino]benzoyl]-, L-(+)-, L-Glutamic acid,4-diamino-6-pteridinyl)methyl]- methylamino]benzoyl]-, L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,hydrate(9ci), L-Glutamicacid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard, Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard, Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material, N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)L-GLUTAMIC ACID, N-[4-[[(2,4-Diamino-6-pteridinyl)methyl] methylamino]benzoyl]-L-glutamic acid, (2S)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid;hydrate, (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric acid;hydrate, (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid;hydrate, (2S)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid;hydrate, (S)-2-(4-[(2,4-DIAMINO-PTERIDIN-6-YLMETHYL)-METHYL-AMINO]-BENZOYLAMINO)-PENTANEDIOIC ACID, 1082707-84-3, 70359-39-6, L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, hydrate (9CI), Methotrexate, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production, meets EP, USP testing specifications